CN111770992A - CRISPR-Cas12j酶和系统 - Google Patents
CRISPR-Cas12j酶和系统 Download PDFInfo
- Publication number
- CN111770992A CN111770992A CN201980014005.0A CN201980014005A CN111770992A CN 111770992 A CN111770992 A CN 111770992A CN 201980014005 A CN201980014005 A CN 201980014005A CN 111770992 A CN111770992 A CN 111770992A
- Authority
- CN
- China
- Prior art keywords
- sequence
- protein
- nucleic acid
- seq
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (47)
- PCT国内申请,权利要求书已公开。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110475316.6A CN113462671B (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
CN202110475336.3A CN113462672A (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811355943 | 2018-11-15 | ||
CN2018113559430 | 2018-11-15 | ||
PCT/CN2019/118702 WO2020098772A1 (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110475336.3A Division CN113462672A (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
CN202110475316.6A Division CN113462671B (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111770992A true CN111770992A (zh) | 2020-10-13 |
CN111770992B CN111770992B (zh) | 2021-04-09 |
Family
ID=70731025
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201980014005.0A Active CN111770992B (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
CN202110475336.3A Pending CN113462672A (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
CN202110475316.6A Active CN113462671B (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110475336.3A Pending CN113462672A (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
CN202110475316.6A Active CN113462671B (zh) | 2018-11-15 | 2019-11-15 | CRISPR-Cas12j酶和系统 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220002691A1 (zh) |
EP (1) | EP3882345A4 (zh) |
JP (1) | JP7460178B2 (zh) |
KR (1) | KR20210142586A (zh) |
CN (3) | CN111770992B (zh) |
AU (1) | AU2019381258B2 (zh) |
BR (1) | BR112021009330A2 (zh) |
CA (1) | CA3120432A1 (zh) |
IL (1) | IL283169A (zh) |
MX (1) | MX2021005723A (zh) |
PH (1) | PH12021551114A1 (zh) |
SG (1) | SG11202105121WA (zh) |
WO (1) | WO2020098772A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113234795A (zh) * | 2021-04-15 | 2021-08-10 | 山东舜丰生物科技有限公司 | 利用Cas蛋白进行核酸检测的方法 |
CN113717962A (zh) * | 2021-09-10 | 2021-11-30 | 武汉艾迪晶生物科技有限公司 | 用于水稻基因编辑的CasΦ-2蛋白及其表达盒子和表达载体 |
CN113881652A (zh) * | 2020-11-11 | 2022-01-04 | 山东舜丰生物科技有限公司 | 新型Cas酶和系统以及应用 |
CN114517190A (zh) * | 2021-02-05 | 2022-05-20 | 山东舜丰生物科技有限公司 | Crispr酶和系统以及应用 |
CN115975986A (zh) * | 2022-08-22 | 2023-04-18 | 山东舜丰生物科技有限公司 | 突变的Cas12j蛋白及其应用 |
CN115992115A (zh) * | 2021-10-26 | 2023-04-21 | 山东舜丰生物科技有限公司 | 新型的crispr酶和系统以及应用 |
WO2023202116A1 (zh) * | 2022-04-20 | 2023-10-26 | 山东舜丰生物科技有限公司 | Cas酶和系统以及应用 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020231380A1 (en) | 2019-03-07 | 2021-09-23 | The Regents Of The University Of California | CRISPR-Cas effector polypeptides and methods of use thereof |
AU2020397041A1 (en) * | 2019-12-04 | 2022-06-09 | Arbor Biotechnologies, Inc. | Compositions comprising a nuclease and uses thereof |
EP4139447A4 (en) * | 2020-04-20 | 2024-05-29 | Univ California | CRISPR SYSTEMS IN PLANTS |
CN111996236B (zh) * | 2020-05-29 | 2021-06-29 | 山东舜丰生物科技有限公司 | 基于crispr技术进行靶核酸检测的方法 |
CN111690773B (zh) * | 2020-06-17 | 2021-08-20 | 山东舜丰生物科技有限公司 | 利用新型Cas酶进行目标核酸检测的方法和系统 |
US20240093228A1 (en) * | 2021-01-22 | 2024-03-21 | Arbor Biotechnologies, Inc. | Compositions comprising a nuclease and uses thereof |
CA3219005A1 (en) * | 2021-06-02 | 2022-12-08 | Guillermo Montoya | Mutant cas12j endonucleases |
WO2023143342A1 (zh) * | 2022-01-29 | 2023-08-03 | 山东舜丰生物科技有限公司 | Cas酶和系统以及应用 |
CN116987693A (zh) * | 2022-04-25 | 2023-11-03 | 上海科技大学 | 一种优化的CRISPR/SpCas12f1系统、工程化向导RNA及其应用 |
CN116716277A (zh) * | 2022-07-07 | 2023-09-08 | 山东舜丰生物科技有限公司 | Cas酶及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105899657A (zh) * | 2013-12-12 | 2016-08-24 | 布罗德研究所有限公司 | 用于改变基因产物表达的crispr-cas系统和方法、结构信息以及诱导型模块化cas酶 |
WO2018035387A1 (en) * | 2016-08-17 | 2018-02-22 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140066379A1 (en) * | 2012-08-30 | 2014-03-06 | Body Organ Biomedical Corp. | Recombinant vector, transgenic fish egg using the same and biomaterial using the same |
JP5774657B2 (ja) * | 2013-10-04 | 2015-09-09 | 国立大学法人京都大学 | エレクトロポレーションを利用した哺乳類の遺伝子改変方法 |
CN107406838A (zh) * | 2014-11-06 | 2017-11-28 | 纳幕尔杜邦公司 | Rna引导的内切核酸酶向细胞中的肽介导的递送 |
WO2016205749A1 (en) * | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
US9790490B2 (en) * | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
CN105296518A (zh) * | 2015-12-01 | 2016-02-03 | 中国农业大学 | 一种用于CRISPR/Cas9技术的同源臂载体构建方法 |
CN106845151B (zh) * | 2015-12-07 | 2019-03-26 | 中国农业大学 | CRISPR-Cas9系统sgRNA作用靶点的筛选方法及装置 |
CN115216459A (zh) * | 2015-12-29 | 2022-10-21 | 孟山都技术公司 | 新型crispr相关转座酶及其用途 |
CA3026110A1 (en) * | 2016-04-19 | 2017-11-02 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
KR20190019168A (ko) * | 2016-06-17 | 2019-02-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 제vi형 crispr 오솔로그 및 시스템 |
CN107784200B (zh) * | 2016-08-26 | 2020-11-06 | 深圳华大生命科学研究院 | 一种筛选新型CRISPR-Cas系统的方法和装置 |
CN106978428A (zh) * | 2017-03-15 | 2017-07-25 | 上海吐露港生物科技有限公司 | 一种Cas蛋白特异结合靶标DNA、调控靶标基因转录的方法及试剂盒 |
CN112004932B (zh) * | 2018-04-20 | 2023-01-10 | 中国农业大学 | 一种CRISPR/Cas效应蛋白及系统 |
CN112020560B (zh) * | 2018-04-25 | 2024-02-23 | 中国农业大学 | 一种RNA编辑的CRISPR/Cas效应蛋白及系统 |
WO2019214604A1 (zh) * | 2018-05-07 | 2019-11-14 | 中国农业大学 | CRISPR/Cas效应蛋白及系统 |
US10934536B2 (en) * | 2018-12-14 | 2021-03-02 | Pioneer Hi-Bred International, Inc. | CRISPR-CAS systems for genome editing |
AU2020231380A1 (en) * | 2019-03-07 | 2021-09-23 | The Regents Of The University Of California | CRISPR-Cas effector polypeptides and methods of use thereof |
-
2019
- 2019-11-15 US US17/294,175 patent/US20220002691A1/en active Pending
- 2019-11-15 MX MX2021005723A patent/MX2021005723A/es unknown
- 2019-11-15 WO PCT/CN2019/118702 patent/WO2020098772A1/zh unknown
- 2019-11-15 JP JP2021527197A patent/JP7460178B2/ja active Active
- 2019-11-15 CN CN201980014005.0A patent/CN111770992B/zh active Active
- 2019-11-15 CA CA3120432A patent/CA3120432A1/en active Pending
- 2019-11-15 SG SG11202105121WA patent/SG11202105121WA/en unknown
- 2019-11-15 AU AU2019381258A patent/AU2019381258B2/en active Active
- 2019-11-15 BR BR112021009330-3A patent/BR112021009330A2/pt unknown
- 2019-11-15 KR KR1020217018362A patent/KR20210142586A/ko not_active Application Discontinuation
- 2019-11-15 CN CN202110475336.3A patent/CN113462672A/zh active Pending
- 2019-11-15 CN CN202110475316.6A patent/CN113462671B/zh active Active
- 2019-11-15 EP EP19884549.7A patent/EP3882345A4/en active Pending
-
2021
- 2021-05-13 IL IL283169A patent/IL283169A/en unknown
- 2021-05-14 PH PH12021551114A patent/PH12021551114A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105899657A (zh) * | 2013-12-12 | 2016-08-24 | 布罗德研究所有限公司 | 用于改变基因产物表达的crispr-cas系统和方法、结构信息以及诱导型模块化cas酶 |
WO2018035387A1 (en) * | 2016-08-17 | 2018-02-22 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113881652A (zh) * | 2020-11-11 | 2022-01-04 | 山东舜丰生物科技有限公司 | 新型Cas酶和系统以及应用 |
CN113881652B (zh) * | 2020-11-11 | 2022-11-22 | 山东舜丰生物科技有限公司 | 新型Cas酶和系统以及应用 |
CN114517190B (zh) * | 2021-02-05 | 2022-12-23 | 山东舜丰生物科技有限公司 | Crispr酶和系统以及应用 |
CN114517190A (zh) * | 2021-02-05 | 2022-05-20 | 山东舜丰生物科技有限公司 | Crispr酶和系统以及应用 |
WO2022166895A1 (zh) * | 2021-02-05 | 2022-08-11 | 山东舜丰生物科技有限公司 | Crispr酶和系统以及应用 |
CN113234795A (zh) * | 2021-04-15 | 2021-08-10 | 山东舜丰生物科技有限公司 | 利用Cas蛋白进行核酸检测的方法 |
CN113234795B (zh) * | 2021-04-15 | 2023-02-24 | 山东舜丰生物科技有限公司 | 利用Cas蛋白进行核酸检测的方法 |
CN113717962A (zh) * | 2021-09-10 | 2021-11-30 | 武汉艾迪晶生物科技有限公司 | 用于水稻基因编辑的CasΦ-2蛋白及其表达盒子和表达载体 |
CN115992115A (zh) * | 2021-10-26 | 2023-04-21 | 山东舜丰生物科技有限公司 | 新型的crispr酶和系统以及应用 |
CN115992115B (zh) * | 2021-10-26 | 2023-09-01 | 山东舜丰生物科技有限公司 | 新型的crispr酶和系统以及应用 |
WO2023202116A1 (zh) * | 2022-04-20 | 2023-10-26 | 山东舜丰生物科技有限公司 | Cas酶和系统以及应用 |
CN115975986A (zh) * | 2022-08-22 | 2023-04-18 | 山东舜丰生物科技有限公司 | 突变的Cas12j蛋白及其应用 |
CN115975986B (zh) * | 2022-08-22 | 2023-08-08 | 山东舜丰生物科技有限公司 | 突变的Cas12j蛋白及其应用 |
WO2024040874A1 (zh) * | 2022-08-22 | 2024-02-29 | 山东舜丰生物科技有限公司 | 突变的Cas12j蛋白及其应用 |
Also Published As
Publication number | Publication date |
---|---|
PH12021551114A1 (en) | 2021-11-22 |
BR112021009330A2 (pt) | 2021-08-17 |
JP2022518329A (ja) | 2022-03-15 |
SG11202105121WA (en) | 2021-06-29 |
AU2019381258B2 (en) | 2024-02-01 |
CN113462672A (zh) | 2021-10-01 |
EP3882345A4 (en) | 2023-02-22 |
JP7460178B2 (ja) | 2024-04-02 |
KR20210142586A (ko) | 2021-11-25 |
US20220002691A1 (en) | 2022-01-06 |
CN111770992B (zh) | 2021-04-09 |
AU2019381258A1 (en) | 2021-07-01 |
CN113462671B (zh) | 2023-09-12 |
IL283169A (en) | 2021-06-30 |
CN113462671A (zh) | 2021-10-01 |
EP3882345A1 (en) | 2021-09-22 |
MX2021005723A (es) | 2021-09-23 |
CA3120432A1 (en) | 2020-05-22 |
WO2020098772A1 (zh) | 2020-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111770992A (zh) | CRISPR-Cas12j酶和系统 | |
CN113136375B (zh) | 新型CRISPR/Cas12f酶和系统 | |
CN112105728A (zh) | CRISPR/Cas效应蛋白及系统 | |
CN112004932B (zh) | 一种CRISPR/Cas效应蛋白及系统 | |
CN113015798B (zh) | CRISPR-Cas12a酶和系统 | |
CN114672473B (zh) | 一种优化的Cas蛋白及其应用 | |
CN114517190B (zh) | Crispr酶和系统以及应用 | |
CN114410609B (zh) | 一种活性提高的Cas蛋白以及应用 | |
CN112020560A (zh) | 一种RNA编辑的CRISPR/Cas效应蛋白及系统 | |
CN114438055B (zh) | 新型的crispr酶和系统以及应用 | |
CN113337502B (zh) | 一种gRNA及其用途 | |
CN113930410A (zh) | 新型CRISPR-Cas12L酶和系统 | |
CN113930411A (zh) | 新型CRISPR-Cas12M酶和系统 | |
CN114277015A (zh) | 新型crispr酶以及应用 | |
CN113930412A (zh) | 新型CRISPR-Cas12N酶和系统 | |
CN113930413A (zh) | 新型CRISPR-Cas12j.23酶和系统 | |
WO2023143150A1 (zh) | 新型Cas酶和系统以及应用 | |
CN115261359A (zh) | 一种新型crispr酶和系统以及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40033057 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20201013 Assignee: Shandong Shunfeng Biotechnology Co.,Ltd. Assignor: CHINA AGRICULTURAL University Contract record no.: X2021980014079 Denomination of invention: Crispr-cas12j enzyme and system Granted publication date: 20210409 License type: Exclusive License Record date: 20211208 |